MedPath

STRIDES PHARMA SCIENCE PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

300

TGA:300

Drug Approvals

STRIDES IBUPROFEN MELTS ibuprofen 200mg orally disintegrating tablets blister pack (488245)

Product Name
STRIDES IBUPROFEN MELTS ibuprofen 200mg orally disintegrating tablets blister pack
Approval Date
May 9, 2025
TGA

Pregabalin-RJIC pregabalin 100 mg capsule bottle (424835)

Product Name
Pregabalin-RJIC pregabalin 100 mg capsule bottle
Approval Date
Feb 5, 2024
TGA

Pregabalin-RJIC pregabalin 300 mg capsule blister (424831)

Product Name
Pregabalin-RJIC pregabalin 300 mg capsule blister
Approval Date
Feb 5, 2024
TGA

Pregabalin-RJIC pregabalin 300 mg capsule bottle (424839)

Product Name
Pregabalin-RJIC pregabalin 300 mg capsule bottle
Approval Date
Feb 5, 2024
TGA

Pregabalin-RJIC pregabalin 50 mg capsule bottle (424833)

Product Name
Pregabalin-RJIC pregabalin 50 mg capsule bottle
Approval Date
Feb 5, 2024
TGA

Pregabalin-RJIC pregabalin 100 mg capsule blister (424810)

Product Name
Pregabalin-RJIC pregabalin 100 mg capsule blister
Approval Date
Feb 5, 2024
TGA

Pregabalin-RJIC pregabalin 150 mg capsule blister (424811)

Product Name
Pregabalin-RJIC pregabalin 150 mg capsule blister
Approval Date
Feb 5, 2024
TGA

Pregabalin-RJIC pregabalin 25 mg capsule bottle (424832)

Product Name
Pregabalin-RJIC pregabalin 25 mg capsule bottle
Approval Date
Feb 5, 2024
TGA

Pregabalin-RJIC pregabalin 200 mg capsule blister (424812)

Product Name
Pregabalin-RJIC pregabalin 200 mg capsule blister
Approval Date
Feb 5, 2024
TGA

Pregabalin-RJIC pregabalin 225 mg capsule bottle (424838)

Product Name
Pregabalin-RJIC pregabalin 225 mg capsule bottle
Approval Date
Feb 5, 2024
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 30
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.